We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Genmab A/S announced that its partner Roche has initiated a Phase II clinical study of R1507 for the treatment of recurrent or refractory sarcoma. Yahoo! Finance
